Department of Radiology
Biomedical Engineering and Bioengineering | Circulatory and Respiratory Physiology | Infectious Disease | Respiratory System | Statistics and Probability | Therapeutics | Virus Diseases
In response to the unmet need for effective treatments for symptomatic patients, research efforts of inhaled therapy for COVID-19 patients have been pursued since the pandemic began. However, inhalation drug delivery to the lungs is sensitive to the lung anatomy and physiology, which can be significantly altered due to the viral infection. The ensued ventilation heterogeneity will change distribution and thus dosimetry of inhaled medications, rendering previous correlations concepts? of pulmonary drug delivery in healthy lungs less reliable. In this study, we first reviewed the recent developments of inhaled therapeutics and vaccines, as well as the latest knowledge of the lung structural variations documented by CT of COVID-19 patients' lungs. We then quantified the volume ratios of the poorly aerated lungs and non-aerated lungs in eight COVID-19 patients, which ranged 2-8% and 0.5-3%, respectively. The need to consider the diseased lung physiologies in estimating pulmonary delivery was emphasized. Diseased lung geometries with varying lesion sites and complexities were reconstructed using Statistical Shape Modeling (SSM). A new segmentation method was applied that could generate patient-specific lung geometries with an increased number of branching generations. The synergy of the CT-based lung segmentation and SSM-based airway variation showed promise for developing representative COVID-infected lung morphological models and investigating inhalation therapeutics in COVID-19 patients.
COVID-19, Airway Remodeling, Inhalation Therapy, Inhaled Vaccine, Bronchial Constriction, Statistical Shape Modeling (SSM)
Rights and Permissions
Copyright (c) 2021 Jinxiang Xi, Brendan Walfield, Xiuhua April Si, Alexander A Bankier. This is an open access article under the CC-BY license (https://creativecommons.org/licenses/by/4.0/).
DOI of Published Version
Xi J, Walfield B, Si XA, Bankier AA. Lung physiological variations in COVID-19 patients and inhalation therapy development for remodeled lungs. SciMedicine Journal. 2021 Sep 1;3(3):198-208.
Xi J, Walfield B, Si XA, Bankier AA. (2021). Lung Physiological Variations in COVID-19 Patients and Inhalation Therapy Development for Remodeled Lungs. COVID-19 Publications by UMass Chan Authors. https://doi.org/10.28991/SciMedJ-2021-0303-1. Retrieved from https://escholarship.umassmed.edu/covid19/318
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Biomedical Engineering and Bioengineering Commons, Circulatory and Respiratory Physiology Commons, Infectious Disease Commons, Respiratory System Commons, Statistics and Probability Commons, Therapeutics Commons, Virus Diseases Commons